Izadora de Souza in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chemotherapy resistance is the cause of failure in most patients with metastatic cancer. NRF2 is an important gene involved in chemotherapy resistance through its ability to regulate genes related to the antioxidant response, as well as prevent the cell from cell death processes, such as ferroptosis. Ferroptosis has been increasingly studied as an alternative in antitumor therapy. Ferropt…
Glioblastoma is an extremely aggressive type of cancer and patients with this type of tumor have an average survival of 12 to 15 months. Almost all patients succumb in the first years after diagnosis of the disease due to resistance to chemotherapy. Standard chemotherapy is performed by administering temozolomide (TMZ) which is an alkylating agent that induces cell death by inducing vario…
Cancer is a leading cause of death worldwide. Although great advances have been made in cancer treatment, chemotherapy resistance remains a great clinical challenge and, as a consequence, it is one of the main causes of failure in most patients with metastatic cancer. NRF2 is an important gene involved in drug resistance and has been identified as amplified in the most aggressive types of…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID